ESC 365 - Rivaroxaban plus aspirin in patients with and without heart failure and chronic coronary or peripheral artery disease: the COMPASS trial

HFA Premium Access

Rivaroxaban plus aspirin in patients with and without heart failure and chronic coronary or peripheral artery disease: the COMPASS trial

Session: Late breaking trial IV - Registries

Topic: Revascularisation

Speaker: Professor K. Branch (Seattle, US)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Professor Kelley Branch

University of Washington, Seattle (United States of America)

4 presentations

0 follower

11 more presentations in this session

Association between sacubitril/valsartan initiation and health status outcomes in heart failure with reduced ejection fraction: findings from the CHAMP-HF registry

Speaker: Doctor Y. Khariton (Kansas City, US)

Discussion - Sacubitril/Valsartan initiation and health status outcomes in HFrEF

Subtle ventricular dysfunction outperforms other risk markers in patients with coronary artery disease

Speaker: Professor D. Kotecha (Birmingham, GB)

Discussion - ARM-CAD

Discussion - COMPASS CHF

Access the full session

Late breaking trial IV - Registries

Speakers: Professor K. Branch, Doctor Y. Khariton, Professor D. Kotecha

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources